Selecting an appropriate protein shake during semaglutide therapy requires consideration of several clinical and practical factors
When both are activated together, GH output exceeds what either signal produces alone
Reproduction 161 (3), 269287
Non-medication strategies For some patients, lifestyle interventions or specialized nutrition and fitness programs can help sustain progress without medication
The evidence consistently identifies several factors that increase risk further: Higher doses (the weight-loss doses of semaglutide and tirzepatide carry higher risk than the lower diabetic doses) Longer duration of treatment Faster rate of weight loss Pre-existing gallstones even asymptomatic ones found on a previous scan Female sex, age over 40, and family history of gallstones (the standard baseline risk factors, amplified by GLP-1 therapy) If several of these apply to you, the risk-benefit balance of your treatment plan is worth a structured discussion
Contact Rejuven Joint Care today to schedule a consultation and embark on your journey toward a life free from the constraints of joint pain